Prot# 6002-INT-001: A Long-Term, Multicenter, Open-Label Safety Study with Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients with Motor Response Complications on Levodopa Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date12/17/047/31/07

Funding

  • PharmaNet, Inc. (6002-INT-001 // 6002-INT-001)
  • Kyowa Hakko Kirin Pharma, Inc. (6002-INT-001 // 6002-INT-001)